The global ertapenem market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Ertapenem is also prescribed for patients undergoing certain types of surgery that poses a risk of infection. Incidence of various bacterial diseases is increasing rapidly that is accelerating the demand for ertapenem drug. Pneumonia acquired in hospital settings due to longer patient stays, is often difficult to treat and exists as the comorbidity to various chronic diseases such as cancer, organ transplant. etc. It also interferes with the disease treatment and may be fatal if not treated with broad-spectrum antibiotics such as carbapenem-based antibiotics.
Browse the full report description of “Global Ertapenem Market Size, Share & Trends Analysis Report by Type (Purity: Above 98% and Purity: Above 99%), and by Application (Injection and Tablet) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/ertapenem-market
Various regional as well as global pharmaceutical companies are assessing feasibility for possible re- launch of generic version of ertapenem in various regions. For instance, in 2021 Dr. Reddy's Laboratories Ltd. is committed to delivering low-cost, innovative medicines to help people live healthier lives. Dr. Reddy offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products. The gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology are major therapeutic areas of focus. Dr. Reddy is present in markets all over the world.
Market Coverage
• The market number available for – 2022-2028
• Base year- 2022
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Kopran Ltd., Canagen Pharma Inc., Conder Co., Taiwan Savior Lifetec Corp., Xiamen Amoipharm Chem. Co. Ltd., Fuan Pharmaceutical (Grp.) Co. Ltd., Pfizer Inc., Merck Co. & Inc., Sumitomo Dainippon Pharma Co., Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Ertapenem market Market Report Segment
By Type
• Purity: Above 98%
• Purity: Above 99%
By Application
• Injection
• Tablet
Global Ertapenem market Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/ertapenem-market